<DOC>
	<DOCNO>NCT01705080</DOCNO>
	<brief_summary>The purpose post market clinical investigation evaluate safety performance EnligHTN™ Renal Denervation System treatment patient uncontrolled hypertension .</brief_summary>
	<brief_title>IntErnational Long-term Follow-up Study Patients With Uncontrolled HyperTensioN</brief_title>
	<detailed_description>This post market , prospective , multicenter , non-randomized , single arm study EnligHTN™ Renal Denervation System . Approximately 500 subject uncontrolled hypertension undergo renal artery ablation approximately 40 investigational site locate internationally follow five ( 5 ) year post procedure .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Calcium Channel Blockers</mesh_term>
	<criteria>Subject ≥ 18 year age time consent Subject must able willing provide write informed consent Subject must able willing comply require followup schedule Subject office Systolic Blood Pressure ≥ 140 mmHg confirmatory visit Subject daytime mean Systolic Ambulatory Blood Pressure &gt; 135 mmHg within 90 day prior procedure Subject establish hypertension ( diagnosed ≥12 month prior baseline ) guideline base drug regimen stable fully tolerate dose consist ≥ 3 antihypertensive medication ( include 1 diuretic ) subject document drug intolerance 2 4 major class antihypertensive ( ACE/ARB , Calcium Channel Blockers , Beta Blockers , diuretic ) unable take 3 antihypertensive drug . Subject significant renovascular abnormality renal artery stenosis &gt; 30 % Subject undergone prior renal angioplasty , renal denervation , indwell renal stent , and/or abdominal aortic stent graft Subject hemodynamically significant valvular heart disease determine study investigator Subject life expectancy le 12 month , determine Investigator Subject participate another clinical study potential impact hypertension management ( pharmaceutical/device/homeopathic ) Subject pregnant , nursing , childbearing potential use adequate contraceptive method Subject active systemic infection Subject renal artery diameter ( ) &lt; 4 mm diameter Subject estimate GFR &lt; 15 mL/min per 1.73 m2 use Modification Diet Renal Disease ( MDRD ) formula Subject renal transplant await renal transplant Subject blood clotting abnormality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Renal Denervation</keyword>
	<keyword>Renal artery</keyword>
</DOC>